Am J Transplant, Volume 5, Suppl 3 Archives - Page 124 of 170 - ATC Abstracts

2015 American Transplant Congress
Kidney Paired Donation: National Activity and Perspectives
T. Dunn,¹ S. Fayek,² C. Marsh,³ P. Abt.⁴
¹Surgery, University of Minnesota, Minneapolis, MN; ²Surgery, Rush University Medical Center, Chicago, IL; ³Surgery, Scripps Health, La Jolla, CA; ⁴Surgery, University of Pennsylvania, Philadelphia, PA.
While utilization of Kidney Paired Donation (KPD) continues to increase, the potential is not fully realized. We surveyed kidney transplant (KTX) professionals to evaluate perceptions…
2015 American Transplant Congress
Renal Mass as a Determinant Factor of Long-Term Post-Donation Anemia
S. Shah,¹ B. Lankowsky,² Z. Zaky,¹ S. Nurko,¹ R. Fatica,¹ S. Gebreselassie,¹ B. Stephany,¹ E. Poggio.¹
¹Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH; ²Case Western Reserve University, SOM, Cleveland, OH.
Living kidney donors lose approximately 50% of renal mass when donating a kidney however, renal function recovers to within 60-70% of baseline within weeks to…
2015 American Transplant Congress
Lung Transplant Patients With Elevated Baseline Pulmonary Arterial Pressures Are More Likely to Recover from Post-Transplant Acute Kidney Injury
B. Stephany,¹ E. Wehbe,² M. Budev.³
¹Nephrology & Hypertension, Cleveland Clinic, Cleveland, OH; ²Nephrology, Wichita, KS; ³Pulmonary, Allergy & Critical Care, Cleveland Clinic, Cleveland, OH.
Purpose: Elevated pre-operative pulmonary arterial pressures predict acute kidney injury (AKI) after lung transplant. It is unknown if the elevated pulmonary pressures predict recovery from…
2015 American Transplant Congress
The Impact of Donor and Recipient Weight Incompatibility on Outcomes in Renal Transplantation
L. Wong,¹ S. Moran,¹ A. Counihan,² P. Cunningham,² P. O'Kelly,¹ P. Conlon.¹
¹Nephrology, Beaumont Hospital, Dublin, Ireland; ²Urology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Background: Kidney transplantation has been proposed as an accelerated model of nephron reduction resulting from the accumulation of repeated insults, both immunologic and non-immunologic events.…
2015 American Transplant Congress
Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients
B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.
University of Cincinnati, Cincinnati.
Background: Contrast-induced nephropathy (CIN) is associated with a significant increase in mortality and morbidity in patients with native kidneys. Data regarding CIN in renal allografts…
2015 American Transplant Congress
Interrogation of Plasma Cell-Rich Acute Rejection in Human Kidney Allografts by Whole Transcriptome Sequencing
L. Mesnard, F. Campagne, H. Yang, D. Dadhania, J. Lee, S. Seshan, M. Suthanthiran, T. Muthukumar.
Weill Medical College of Cornell University, New York.
Plasma cell-rich acute rejection (PCRAR, plasma cells constituting >20% of the allograft infiltrating cells) portends poor prognosis.To gain better mechanistic insights and develop diagnostic biomarkers,…
2015 American Transplant Congress
First Dose Tacrolimus Level Is Better Than CYP3A5 Genotyping in Prediction of Target Tacrolimus Dose
N. Townamchai,¹ W. Chancharoenthana,¹ S. Wattanatorn,¹ S. Vadcharavivad,² P. Chariyavilaskul,³ A. Leelahavanichkul,⁴ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
¹Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ²Department of Pharmacy Practice, Chulalongkorn University, Bangkok, Thailand; ³Pharmacokinetic Research Unit, Chulalongkorn University, Bangkok, Thailand; ⁴Department of Microbiology, Chulalongkorn University, Bangkok, Thailand.
Background: Tacrolimus dose highly varies among Asian kidney transplant recipients. This can be explained by variety of CYP3A5 expression. CYP3A5 genotyping is highly recommended for…
2015 American Transplant Congress
Liver Fabrication Using Whole Organ Scaffold for Transplantable Graft in Large Animal
K. Inomata,¹ H. Yagi,¹ K. Tazima,¹ K. Sugiyama,¹ M. Hieda,¹ T. Hibi,¹ Y. Abe,¹ M. Kitago,¹ M. Shinoda,¹ O. Itano,¹ T. Akaike,² Y. Kitagawa.¹
¹Surgery, Keio University, Tokyo, Japan; ²Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Tokyo, Japan.
Background and aims: Orthotopic liver transplantation is only effective treatment for end-stage liver disease, however it is limited by shortage of donor livers. Therefore, novel…
2015 American Transplant Congress
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function
D. Felix,¹ B. Astor,² D. Hager,¹ A. Djamali.²
¹Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI; ²Department of Medicine - Division of Nephrology, University of Wisconsin Hospital and Clinics, Madison, WI.
The impact of selection of induction immunosuppression agent on incidence of delayed graft function (DGF) remains unclear. A total of 1,980 deceased donor kidney transplant…
2015 American Transplant Congress
Blocking CD40/CD154 Co-Stimulation Prevents Acute Antibody-Mediated Renal Allograft Rejection Induced by Memory CD4 T Cells
V. Gorbacheva, R. Fan, A. Valujskikh.
Immunology, The Cleveland Clinic, Cleveland, OH.
Immunosuppression-resistant alloreactive memory CD4 T cells induce robust responses against organ transplants. In murine heart allograft recipients donor-reactive memory CD4 T cells provide help for…